We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Scraps Suffixes for Older Biologics’ Proper Names
FDA Scraps Suffixes for Older Biologics’ Proper Names
The FDA has decided not to require four-letter suffixes for already-approved or licensed biological products with no FDA-designated suffix in their proper names.